BridgeMD
New treatment option for COPD - Chronic Obstructive Pulmonary Disease
Official title Combined Posture Correction and Resistive Respiratory Muscles Training in COPD With FHP
ClinicalTrials.gov ID: NCT07293429
What this study is testing
- What it's testing
- Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation, often exacerbated by postural abnormalities such as forward head posture (FHP). FHP can lead to significant alterations in breathing patterns, reducing the efficiency of respiratory muscles and impairing lung function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Patients of COPD at stage 1 and 2
- COPD with forward head posture.
- Craniovertebral angle \< 53 degrees (20)
- Age 40-60
- Both genders
You likely can't join if
- COPD with severe complications (respiratory infections, acute exacerbations, pulmonary hypertension)
- COPD with cardiovascular complications (Cor Pulmonale, atherosclerosis, risk of venous thromboembolism)
- Unstable respiratory, neurological, and cardiovascular conditions
- Congenital Cervical/spinal deformity
- Patients with frozen shoulder, shoulder, cervical radiculopathy)
- Uncontrolled underlying conditions(22)
See the full eligibility criteria
- Patients of COPD at stage 1 and 2
- COPD with forward head posture.
- Craniovertebral angle \< 53 degrees (20)
- Age 40-60
- Both genders
- Spirometric evidence of significant chronic air-flow limitation (ie, FEV1 of 50% of predicted and FEV1/FVC ratio of 70% of predicted) in whom COPD had been diagnosed (21)
- Persistent dyspnea with a self-rated intensity of ⩾6 (out of 10) on a visual analogue
- Having muscular tightness (pectoralis major and minor, upper trapezius, sternocleidomastoid)
- COPD with severe complications (respiratory infections, acute exacerbations, pulmonary hypertension)
- COPD with cardiovascular complications (Cor Pulmonale, atherosclerosis, risk of venous thromboembolism)
- Unstable respiratory, neurological, and cardiovascular conditions
- Congenital Cervical/spinal deformity
- Patients with frozen shoulder, shoulder, cervical radiculopathy)
- Uncontrolled underlying conditions(22)
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.